Teligent Inc. (NASDAQ:TLGT)’s share price traded down 2.4% during trading on Friday . The stock traded as low as $8.08 and last traded at $8.09, with a volume of 220,079 shares changing hands. The stock had previously closed at $8.29.

Several equities analysts have commented on the stock. Zacks Investment Research raised shares of Teligent from a “hold” rating to a “buy” rating and set a $9.25 target price on the stock in a report on Tuesday. JMP Securities began coverage on shares of Teligent in a report on Wednesday, June 29th. They set a “hold” rating on the stock. TheStreet raised shares of Teligent from a “sell” rating to a “hold” rating in a report on Thursday, June 23rd. Raymond James Financial Inc. began coverage on shares of Teligent in a report on Wednesday, June 22nd. They set a “strong-buy” rating and a $11.00 price target on the stock. Finally, Oppenheimer Holdings Inc. reaffirmed a “hold” rating on shares of Teligent in a report on Tuesday, April 26th. Four equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $9.81.

The firm’s market cap is $431.37 million. The company has a 50 day moving average of $6.82 and a 200-day moving average of $6.23.

Teligent (NASDAQ:TLGT) last released its quarterly earnings data on Thursday, April 28th. The company reported $0.02 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.03) by $0.05. The business had revenue of $15.70 million for the quarter, compared to analysts’ expectations of $14.33 million. The firm’s revenue was up 46.7% compared to the same quarter last year. Analysts predict that Teligent Inc. will post $0.01 earnings per share for the current year.

A number of large investors have added to or reduced their stakes in the stock. Columbus Circle Investors acquired a new stake in Teligent during the fourth quarter valued at approximately $2,534,000. Russell Frank Co purchased a new stake in shares of Teligent during the fourth quarter worth about $3,605,000. Turner Investments L.P. purchased a new stake in shares of Teligent during the fourth quarter worth about $7,196,000. Finally, Pembroke Management LTD purchased a new stake in shares of Teligent during the fourth quarter worth about $28,600,000.

Teligent, Inc, formerly IGI Laboratories, Inc, is a specialty generic pharmaceutical company. The Company markets and sells generic injectable pharmaceutical products under its own label in the United States and Canada. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.